Masimo Corp. Stock
Masimo Corp. Stock
Masimo Corp. gained 0.760% compared to yesterday.
Masimo Corp. is currently one of the favorites of our community with 14 Buy predictions and no Sell predictions.
As a result the target price of 172 € shows a positive potential of 42.62% compared to the current price of 120.6 € for Masimo Corp..
Pros and Cons of Masimo Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | 0.760% | 1.858% | 5.282% | -26.887% | 8.453% | -16.655% | -44.679% |
| Icu Medical Inc. | 0.000% | 1.527% | 6.400% | -17.391% | 7.258% | -18.405% | -25.281% |
| Bio-Rad Labs Inc. A | -1.060% | 0.072% | 5.995% | -17.110% | 7.639% | -33.920% | -44.257% |
| Neogen Corp. | 3.700% | -1.205% | 36.667% | -27.434% | 33.333% | - | - |
Comments
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
News
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
On Nov. 14, 2025, 4D Advisors, LLC disclosed in a regulatory filing that it sold out its entire position in Masimo (NASDAQ:MASI). The sale was valued at $7.57 million.
According to a filing with the
